That is true, however I think it's fair to make the point that all Venture Capital firms have the same structural incentive to treat companies (equity) as products, to be traded in a marketplace, and consequently are primarily focused on the net worth (capital gain) return from trading that equity versus the ongoing value-added by the operating business (dividend). I think that's where the 'taste-for-blood' comes from. That fundamental incentive affects how institutional VCs view the founders of a company (less so as partners and more so as employees in a sense). I think that's what this guy is reacting too, rightly or wrongly.